Prescription drug · NDA
Verquvo (Vericiguat) NDC 0006-5029
Vericiguat 5 mg/1 · Tablet, Film coated · Oral · Merck Sharp & Dohme LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0006-5029-01 | 00006502901 | 14 TABLET, FILM COATED in 1 BOTTLE (0006-5029-01)Marketed from Feb 1, 2021 | |
| 0006-5029-02 | 00006502902 | 30 TABLET, FILM COATED in 1 BOTTLE (0006-5029-02)Marketed from Feb 1, 2021 | |
| 0006-5029-04 | 00006502904 | 10 BLISTER PACK in 1 CARTON (0006-5029-04) / 10 TABLET, FILM COATED in 1 BLISTER PACK (0006-5029-03)Marketed from Feb 1, 2021 | |
| 0006-5029-06 | 00006502906 | 1 BOTTLE in 1 CARTON (0006-5029-06) / 14 TABLET, FILM COATED in 1 BOTTLE (0006-5029-05)Marketed from Feb 1, 2021 · Sample package |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Verquvo
- Generic name (nonproprietary)
- vericiguat
- Active ingredients
- Vericiguat — 5 mg/1
- Dosage form
- Tablet, Film coated
- Route
- Oral
- Labeler
- Merck Sharp & Dohme LLCNDC labeler code 0006
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 214377
- Marketing start
- Listing expires
- Other FDA classes
- Guanylate Cyclase Stimulators (Mechanism)
- Identifiers
- Product ID 0006-5029_13b78d9a-fa62-4fcf-8a33-233bc48faccbSPL ID 13b78d9a-fa62-4fcf-8a33-233bc48faccbSPL set ID 17056d73-1b1b-4bf2-9c07-b7a9367f0d6dRxCUI 2475846, 2475852, 2475854, 2475856, 2475858, 2475860UNII LV66ADM269UPC 0300065029023, 0300065030012, 0300065028026
- Pharmacologic class
- Soluble Guanylate Cyclase Stimulator
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N400006502901followed by a unit qualifier and the quantityPackage 00006-5029-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
VERQUVO ® is indicated to reduce the risk of cardiovascular death and heart failure (HF) hospitalization following a hospitalization for heart failure or need for outpatient IV diuretics, in adults with symptomatic chronic HF and ejection fraction less than 45% [see Clinical Studies (14) ] . VERQUVO is a soluble guanylate cyclase (sGC) stimulator, indicated to reduce the risk of cardiovascular death and heart failure (HF) hospitalization following a hospitalization for heart failure or need for outpatient IV diuretics, in adults with symptomatic chronic HF and ejection fraction less than 45%. ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 0006-5029
- What is NDC 0006-5029?
- 0006-5029 is the product NDC for Verquvo (vericiguat), Vericiguat 5 mg/1 tablet, film coated, listed with the FDA by Merck Sharp & Dohme LLC. It has 4 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Verquvo (Vericiguat).
- What is the active ingredient?
- Vericiguat.
- Who is the labeler?
- Merck Sharp & Dohme LLC, NDC labeler code 0006. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Verquvo?
- 2 other product NDCs are listed under this name. See all Verquvo NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Verquvo products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Verquvovericiguat | Vericiguat 10 mg/1 | Tablet, Film coatedOral | Merck Sharp & Dohme LLC | 0006-5030 | 00006-5030-0100006-5030-0200006-5030-04 |
| Verquvovericiguat | Vericiguat 2.5 mg/1 | Tablet, Film coatedOral | Merck Sharp & Dohme LLC | 0006-5028 | 00006-5028-0100006-5028-0200006-5028-04+1 more |
Other NDCs under NDA 214377
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Verquvovericiguat | Vericiguat 10 mg/1 | Tablet, Film coatedOral | Merck Sharp & Dohme LLC | 0006-5030 |
| Verquvovericiguat | Vericiguat 2.5 mg/1 | Tablet, Film coatedOral | Merck Sharp & Dohme LLC | 0006-5028 |